실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
738누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-10 · 마지막 7월 13일
AntibodystaleGruppo Italiano Malattie EMatol…Preclinical

idelalisib and rituximab (idelalisib and rituximab)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleInternational Extranodal Lympho…Phase 2

Bendamustine and Rituximab (Bendamustine and Rituximab)

Marginal Zone B-cell Lymphoma · Marginal Zone B-cell Lymphoma

#MarginalZoneB-cellLymphoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 91%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

R-CHOP (Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone, Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone (R-CHOP))

Non-Hodgkin's B-cell Lymphoma; Lymphoma Non-Hodgkin · Non-Hodgkin's B-cell Lymphoma

#Non-HodgkinsB-cellLymphoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMeletios A. DimopoulosPhase 2

Bortezomib, Rituximab, Dexamethasone (Bortezomib, Rituximab, Dexamethasone)

Waldenstrom's Macroglobulinemia · Waldenstrom's Macroglobulinemia

#WaldenstromsMacroglobulinemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of CagliariPreclinical

Belimumab in SLE patients / Rituximab in RA patients (Belimumab in SLE patients / Rituximab in RA patients)

Systemic Lupus Erythematosus; Rheumatoid Arthritis · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleFondazione Italiana Linfomi - E…Phase 2

Bortezomib-Rituximab-Bendamustine (Bortezomib-Rituximab-Bendamustine)

Waldenstrom's Macroglobulinemia · Waldenstrom's Macroglobulinemia

#WaldenstromsMacroglobulinemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRuijin HospitalPhase 2

Zanubrutinib + Rituximab + MTX ± Selinexor (Zanubrutinib + Rituximab + MTX ± Selinexor)

Central Nervous System Lymphoma · Central Nervous System Lymphoma

#CentralNervousSystemLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleGenta IncorporatedPhase 2

Oblimersen-rituximab-fludarabine (Oblimersen-rituximab-fludarabine)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleChipscreen Biosciences, Ltd.Phase 3

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP, R-CHOP(Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone))

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of UlmPhase 3

Dexamethasone, Rituximab, Cyclophosphamide (Dexamethasone, Rituximab, Cyclophosphamide)

Waldenström's Macroglobulinemia · Waldenström's Macroglobulinemia

#WaldenstrmsMacroglobulinemia#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of UlmPhase 3

Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib (Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib)

Waldenström's Macroglobulinemia · Waldenström's Macroglobulinemia

#WaldenstrmsMacroglobulinemia#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRocheApproved

rituximab combined with corticosteroids (rituximab combined with corticosteroids)

Primary Membranous Nephropathy · Primary Membranous Nephropathy

#PrimaryMembranousNephropathy#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSingapore General HospitalPhase 1

bortezomib, rituximab, ifosphamide, etoposide, carboplatin (bortezomib, rituximab, ifosphamide, etoposide, carboplatin)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab, Bendamustine, Cytarabine (Rituximab, Bendamustine, Cytarabine)

Lymphoma, Mantle-Cell · Lymphoma, Mantle-Cell

#LymphomaMantle-Cell#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleMedical College of WisconsinPhase 3

Cyclophosphamide and Rituximab (Cyclophosphamide and Rituximab)

Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma · Recurrent Grade 1 Follicular Lymphoma

#RecurrentGrade1FollicularLymphom#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Rituximab maintenance therapy (Rituximab maintenance therapy)

Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma · Recurrent Grade 1 Follicular Lymphoma

#RecurrentGrade1FollicularLymphom#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

Rituximab (RTX, Rituximab, Rituximab (RTX) and Azathioprine (AZA))

Granulomatous and Lymphocytic Interstitial Lung Disease · Granulomatous and Lymphocytic Interstiti

#GranulomatousandLymphocyticInter#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNantes University HospitalPreclinical

CEEP-RITUXIMAB (CEEP-RITUXIMAB)

Lymphoma, Large-Cell, Diffuse · Lymphoma, Large-Cell, Diffuse

#LymphomaLarge-CellDiffuse#Antibody#Preclinical#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleThe Lymphoma Academic Research …Phase 1

Everolimus and rituximab (Everolimus and rituximab)

Non-Hodgkin's Lymphomas · Non-Hodgkin's Lymphomas

#Non-HodgkinsLymphomas#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSeoul National University Hospi…Phase 2

bendamustine plus rituximab (bendamustine plus rituximab)

Marginal Zone B-cell Lymphoma · Marginal Zone B-cell Lymphoma

#MarginalZoneB-cellLymphoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 81.8%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab-CHOP-Alemtuzumab (Rituximab-CHOP-Alemtuzumab)

Chronic Lymphocytic Leukaemia; Patients Resistant to a Purine Analogous · Chronic Lymphocytic Leukaemia

#ChronicLymphocyticLeukaemia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleM.D. Anderson Cancer CenterPhase 2

^111 In Ibritumomab Tiuxetan (^111 In Ibritumomab Tiuxetan)

Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 0.8%임상시험 1상태 DISCONTINUED
AntibodystaleTokyo UniversityPhase 3

Double-Blind Rituximab (Double-Blind Rituximab)

Scleroderma, Systemic; Skin Sclerosis · Scleroderma, Systemic

#SclerodermaSystemic#Antibody#Phase3#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleInstitute of Hematology & Blood…Phase 2

Zanubrutinib, Fludarabine, cyclophosphamide and rituximab (Zanubrutinib, Fludarabine, cyclophosphamide and rituximab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleInstitute of Hematology & Blood…Phase 2

Zanubrutinib, bendamustine, rituximab (Zanubrutinib, bendamustine, rituximab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE

96 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기